Galapagos, a biotechnology company headquartered in Belgium, plans to split into two entities: a newly formed company (name to be announced at a later date) that will...
23.07.2019
- Galapagos and Gilead Sciences have agreed a ten-year “multi-billion dollar collaboration” to create what they say will be a global R&D leader based in Europe and engaged in...
04.10.2012
- From its base in a business park outside the city of Ghent, Belgium's biotech industry is attracting a global following, benefiting from years of patient investment, promising...
